Global Antiemetics Market 2018-2023 : Top Key Players (ABBOTT LABORATORIES, NOVARTIS AG, APHIOS CORP., ASTELLAS PHARMA INC., AUROBINDO PHARMA, DAIICHI SANKYO COMPANY LTD. and Others)

Emesis is a devastating adverse effect of surgery, poisoning, chemotherapy, vestibular imbalance, medication, radiotherapy and during pregnancy. Emesis itself is not a disease but an indication of a stressed physiological condition. During the last decades, extraordinary technological advances have made innovations in most of the disease therapies, including cancer therapies, which is the most common cause of emesis.

Antiemetic drug market is population driven and mostly depends on the number of chemotherapy and radiation therapy sessions performed in specific geographic regions that have high cancer burden and utilize chemotherapy and radiation therapy for cancer treatment. Antiemetics are used to suppress nausea and vomiting associated with CINV, PINV, NVP, RINV, motion sickness and vestibular sickness. 5-HT3 receptor antagonists and NK1 receptor antagonists are the most frequently used antiemetic drug categories.

Download a PDF Sample of this Report @ http://orbisresearch.com/contacts/request-sample/2224003#utm_source=shreyas

The global market for antiemetics in 2017 was nearly REDACTED and is expected to reach REDACTED during the forecast period of 2018-2023. The 5-HT3 receptor antagonist market accounts for the largest market share (REDACTED) of the global antiemetic market. NK1 receptor antagonists are the second largest antiemetic drug segment. NK1 receptor antagonists antiemetic drug market is expected to increase at the rate of REDACTED CAGR, thanks to the approval of the U.S.

Food and Drug Administration(FDA), commercial launch of new drug candidates, and the existing pipeline which is likely to hit the market in by 2023. Anticholinergics and benzodiazepines are the smallest antiemetic market segments, accounting for approximately REDACTED of the overall market share.

Access the complete report with TOC & List of Tables @ http://orbisresearch.com/reports/index/antiemetics-technologies-and-global-markets#utm_source=shreyas

Based on applications CINV contribution to antiemetic drug was approximately REDACTED in 2017. Motion sickness and vestibular disorder is the second largest segment by application, accounting for approximately REDACTED in 2017. The CINV market is expected to rise by a CAGR REDACTED during the forecast period. North America is the leading contributor to antiemetic drug market, accounting for about REDACTED of the antiemetic drug market. Middle East and Africa antiemetic market is expected to grow at the highest rate (REDACTED CAGR) during the forecast period.

Companies Mentioned:

ABBOTT LABORATORIES
APHIOS CORP.
ASTELLAS PHARMA INC.
AUROBINDO PHARMA
DAIICHI SANKYO COMPANY LTD.
EISAI CO., INC.
Hoffmann-La Roche AG
GLAXOSMITHKLINE PLC
HELSINN HEALTHCARE SA
HERON THERAPEUTICS, INC.
IPCA LABORATORIES, LTD.
KYOWA HAKKO KIRIN PHARMA, INC.
MERCK & CO., INC.
NOVARTIS AG
SANOFI AVENTIS
TESARO, INC.
TEVA PHARMACEUTICAL INDUSTRIES LTD.

Enquiry before buying report @ http://orbisresearch.com/contacts/enquiry-before-buying/2224003#utm_source=shreyas

Table of Content

Chapter 1 Introduction
Chapter 2 Summary and Highlights
Chapter 3 Overview
Chapter 4 Market and Technology Background
Chapter 5 Market Breakdown by Drug Class
Chapter 6 Market Breakdown by Application
Chapter 7 Market Breakdown by Region
Chapter 8 Patent Review/New Developments
Chapter 9 Pipeline Analysis
Chapter 10 Regulatory Landscape
Chapter 11 Company Profiles
Chapter 12 Appendix: Abbreviations

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Email: sales@orbisresearch.com

This release was published on openPR.